Stephen DeWall

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Vincent Meininger, Angela Genge, Leonard H van den Berg et al. · The Lancet Neurology · 2017 · 85 citations · Full text

Life Sciences, Neurology, Neuroscience +10

A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus

Elizabeth McKie, Juliet Reid, Prafull Mistry et al. · PLoS ONE · 2016 · 80 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose antiinterleukin- 18 mAb GSK1070806 in healthy and obese subjects

Prafull Mistry, Juliet Reid, Isabelle Pouliquen et al. · International Journal of Clinical Pharmacology and Therapeutics · 2014 · 41 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +10

False-positive immunogenicity responses are caused by CD20+ B cell membrane fragments in an anti-ofatumumab antibody bridging assay

Keguan Chen, Jerry G. Page, Ann Schwartz et al. · Journal of Immunological Methods · 2013 · 33 citations

Life Sciences, Immunology, Oncology +14

First in Human Study with GSK2857916, an Antibody Drug Conjugated to Microtubule-Disrupting Agent Directed Against B-Cell Maturation Antigen (BCMA) in Patients with Relapsed/Refractory Multiple Myeloma (MM): Results from Study BMA117159 Part 1 Dose Escalation

Adam D. Cohen, Rakesh Popat, Suzanne Trudel et al. · Blood · 2016 · 26 citations

Medicine, Oncology, Pharmacology +17